Back to Search
Start Over
A Prospective, Randomized, Open-Label Trial of Atorvastatin versus Rosuvastatin in the Prevention of Contrast-Induced Acute Kidney Injury, Worsened Renal Function at 30 Days, and Clinical Events After Acute Coronary Angiography: the PRATO-ACS-2 Study.
- Source :
- CardioRenal Medicine; 2020, Vol. 10 Issue 5, p288-301, 14p
- Publication Year :
- 2020
Details
- Language :
- English
- ISSN :
- 16643828
- Volume :
- 10
- Issue :
- 5
- Database :
- Complementary Index
- Journal :
- CardioRenal Medicine
- Publication Type :
- Academic Journal
- Accession number :
- 145947898
- Full Text :
- https://doi.org/10.1159/000506857